Eric Lasker, an executive at Varda Space Industries, and Sita Sonty, former CEO of Space Tango, explore the revolutionary potential of manufacturing pharmaceuticals in space. They discuss how microgravity can enhance drug development, particularly for personalized gene therapies. The duo dives into the challenges of retrieving space-made products and highlights a cancer therapeutic study conducted in orbit. Their conversation not only paints a picture of future healthcare innovations but also emphasizes the importance of equitable access to these groundbreaking therapies.